Breast Cancer Clinical Trial

A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

Summary

The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Eligible participants will include adult men and women (aged 18 and older) who can understand and communicate in English
meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian or colorectal cancers
have insurance coverage for genetic testing.

Exclusion Criteria:

Under 18 years old - professional guidelines do not recommend genetic testing for cancer risk in minors.
Does not speak English.
Does not have insurance.

Study is for people with:

Breast Cancer

Estimated Enrollment:

120

Study ID:

NCT02517554

Recruitment Status:

Completed

Sponsor:

Abramson Cancer Center at Penn Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Union Hospital
Elkton Maryland, 21921, United States
Cape Regional Medical Center
Cape May Court House New Jersey, 08210, United States
Kennedy Health
Sewell New Jersey, 08080, United States
Shore Cancer Center
Somers Point New Jersey, 08244, United States
Gettysburg Cancer Center
Gettysburg Pennsylvania, 17325, United States
Drexel Cancer Care at Hahnemann
Philadelphia Pennsylvania, 19102, United States
Abramson Cancer Center of the University of Pennsylvania
Philadelphia Pennsylvania, 19104, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

120

Study ID:

NCT02517554

Recruitment Status:

Completed

Sponsor:


Abramson Cancer Center at Penn Medicine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.